New Delhi [India], April 3: Niva Bupa Health Insurance Company Limited, one of India's leading standalone health insurers, has been recognized with multiple prestigious industry recognitions in the last financial year making it one of the most awarded health insurance brands in the country.
The said allegations were made by one Mukesh Singh who appeared as party-in-person and alleged that litigations over environmental issues such as banning firecrackers is nothing but a conspiracy brewed by foreign agencies.
Niel Nitin Mukesh has come a long way in his career. In a journey spanning over 18 years, he has proved his mettle time and again with his acting prowess, especially in projects such as 'Johnny Gaddaar', 'New York', and 'Jail' among others. Credits also go to his "Guru" and veteran actor
Bengaluru (Karnataka) [India], April 3: Epilepsy affects about 50 million people worldwide, making it one of the most common neurological disorders. In India, nearly 10 million people live with epilepsy, yet 70% of patients in rural areas do not receive proper medical care due to a lack of a
Nashik (Maharashtra) [India], April 3: The Board of Directors of Nashik-based KBC Global Ltd, BSE - 541161, engaged in the business of construction and real estate development, in the meeting held on March 28, has fixed April 4th as the record date to determine eligible shareholders entitle
Congress leader Randeep Surjewala on Thursday expressed concern over the 26 per cent tariffs imposed by US on India and criticised Prime Minister Narendra Modi over the issue.
Faced with President Donald Trump's reciprocal tariffs, India on Thursday said it is studying the opportunities that may arise from this new development in US trade policy.
The Public Works Department (PWD) Minister of Himachal Pradesh, Vikramaditya Singh, on Thursday, criticised the central government over the recently passed Waqf Amendment Bill in the Lok Sabha, alleging it serves as a distraction from pressing national issues like unemployment, inflation, a
The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the pharmaceutical sector, has raised concerns about potential future trade restrictions on drug exports.
Congress top brass and the Leader of Opposition in the Lok Sabha, Rahul Gandhi, launched a sharp critique of the Union Government's foreign policy, spotlighting China's occupation of Indian territory and the recent US tariff hike.